These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9475500)

  • 1. Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat.
    Yamashita K; Wiessner C; Lindholm D; Thoenen H; Hossmann KA
    Metab Brain Dis; 1997 Dec; 12(4):271-80. PubMed ID: 9475500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.
    Schäbitz WR; Schwab S; Spranger M; Hacke W
    J Cereb Blood Flow Metab; 1997 May; 17(5):500-6. PubMed ID: 9183287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.
    Schäbitz WR; Sommer C; Zoder W; Kiessling M; Schwaninger M; Schwab S
    Stroke; 2000 Sep; 31(9):2212-7. PubMed ID: 10978054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor.
    Yanamoto H; Nagata I; Sakata M; Zhang Z; Tohnai N; Sakai H; Kikuchi H
    Brain Res; 2000 Mar; 859(2):240-8. PubMed ID: 10719070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem
    Ravina K; Briggs DI; Kislal S; Warraich Z; Nguyen T; Lam RK; Zarembinski TI; Shamloo M
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model.
    Takeshima Y; Nakamura M; Miyake H; Tamaki R; Inui T; Horiuchi K; Wajima D; Nakase H
    Neurosurgery; 2011 May; 68(5):1334-41. PubMed ID: 21307800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats.
    Jiang Y; Wei N; Lu T; Zhu J; Xu G; Liu X
    Neuroscience; 2011 Jan; 172():398-405. PubMed ID: 21034794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous brain-derived neurotrophic factor prevents postischemic downregulation of [3H]muscimol binding to GABA(A) receptors in the cortical penumbra.
    Sommer C; Kollmar R; Schwab S; Kiessling M; Schäbitz WR
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):24-30. PubMed ID: 12654502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
    Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.
    Jiang N; Finklestein SP; Do T; Caday CG; Charette M; Chopp M
    J Neurol Sci; 1996 Aug; 139(2):173-9. PubMed ID: 8856649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
    Jiang N; Zhang RL; Baron BM; Chopp M
    J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice.
    Shi Q; Zhang P; Zhang J; Chen X; Lu H; Tian Y; Parker TL; Liu Y
    Neurosci Lett; 2009 Nov; 465(3):220-5. PubMed ID: 19703519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.
    Britton P; Lu XC; Laskosky MS; Tortella FC
    Life Sci; 1997; 60(20):1729-40. PubMed ID: 9150412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
    Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promotion of cerebral ischemia recovery in rats by laminin-binding BDNF.
    Han Q; Li B; Feng H; Xiao Z; Chen B; Zhao Y; Huang J; Dai J
    Biomaterials; 2011 Aug; 32(22):5077-85. PubMed ID: 21529937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats.
    Tu XK; Yang WZ; Wang CH; Shi SS; Zhang YL; Chen CM; Yang YK; Jin CD; Wen S
    Inflammation; 2010 Oct; 33(5):344-52. PubMed ID: 20204486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke.
    Berger C; Schabitz WR; Wolf M; Mueller H; Sommer C; Schwab S
    Exp Neurol; 2004 Feb; 185(2):305-12. PubMed ID: 14736512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.